Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | TLR9 | Q9NR96 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.43 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.43 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.43 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.43 |
| ▸ | TTR | P02766 | 1/20 | 0.43 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.43 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.43 |
| ▸ | RARB | P10826 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL377595 | 0.87 | MAPK1 (0.51) | GPR35CYP3A4KMT2AMEN1NPC1 | |
| SCHEMBL823830 | 0.86 | ALDH1A1 (0.50) | CYP3A4KMT2AMEN1NPC1TLR9 | |
| SCHEMBL1429398 | 0.83 | TSHR (0.54) | KMT2AMEN1NPC1TLR9MAPT | |
| SCHEMBL16295396 | 0.83 | KDM4E (0.54) | CYP3A4KMT2AMEN1NPC1TLR9 | |
| SCHEMBL20476360 | 0.83 | GPR35 (0.47) | GPR35CYP3A4KMT2ANPC1MAPT | |
| SCHEMBL9368502 | 0.82 | MAPT (0.60) | CYP3A4KMT2AMEN1NPC1TLR9 | |
| SCHEMBL1857266 | 0.82 | MAPK1 (0.51) | CYP3A4KMT2AMEN1NPC1TLR9 | |
| SCHEMBL27357985 | 0.82 | ATM (0.51) | CYP3A4KMT2AMEN1NPC1TLR9 | |
| SCHEMBL1852678 | 0.81 | GPR35 (0.56) | GPR35CYP3A4KMT2ANPC1MAPT | |
| SCHEMBL11341366 | 0.81 | NPC1 (0.47) | CYP3A4KMT2AMEN1NPC1TLR9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0296221-B1 | PROCESS FOR PREPARING 4,6-DINITRORESORCINOL | THE DOW CHEMICAL COMPANY (US) | 1992-05-13 | — | — | EP | claimed |
| EP-0296221-A4 | PROCESS FOR PREPARING 4,6-DINITRORESORCINOL. | STANFORD RES INST INT (US) | 1989-04-24 | — | — | EP | claimed |
| EP-0296221-A1 | PROCESS FOR PREPARING 4,6-DINITRORESORCINOL. | STANFORD RES INST INT (US) | 1988-12-28 | — | — | EP | claimed |
| WO-1988005038-A1 | PROCESS FOR PREPARING 4,6-DINITRORESORCINOL | SRI INTERNATIONAL (US) | 1988-07-14 | — | — | WO | claimed |
| US-4745232-A | NITRATION, PRECIPITATION | SRI INTERNATIONAL (US) | 1988-05-17 | — | — | US | claimed |
| US-10123978-B2 | Patch for treating dermatophytosis | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2018-11-13 | — | — | US | disclosed |
| EP-2881114-B1 | ANTI-TRICHOPHYTIC ADHESIVE PATCH | MEIJI SEIKA PHARMA CO LTD (JP) | 2018-09-05 | — | — | EP | disclosed |
| US-20180200199-A1 | PATCH FOR TREATING DERMATOPHYTOSIS | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2018-07-19 | — | — | US | disclosed |
| US-9549988-B2 | Pharmaceutical compounds targeted by MIF affinity-tethered moieties | RJS Biologics (US) | 2017-01-24 | — | — | US | disclosed |
| EP-2669274-B1 | TOPICAL ANTIFUNGAL AGENT | MEIJI SEIKA PHARMA CO LTD (JP) | 2015-11-18 | — | — | EP | disclosed |
| CN-103339112-B | Topical antifungal agents | MEIJI SEIKA PHARMA CO.,LTD. (JP) | 2015-08-12 | — | — | CN | disclosed |
| US-20150209301-A1 | PATCH FOR ANTI-DERMATOPHYTOSIS | NICHIBAN COMPANY LIMITED (JP) | 2015-07-30 | — | — | US | disclosed |
| CN-1699363-A | Vla-4 inhibitors | DAICHI PHARMACEUTICAL CO LTD (JP) | 2005-11-23 | — | — | CN | disclosed |
| CN-1483024-A | Vla-4 inhibitors | ��һ��������ҩ��ʽ���� | 2004-03-17 | — | — | CN | disclosed |
| CN-1350534-A | Substituted bicyclic heteroaryl compounds as integrin antagonists | AVENTIS PHARMA LTD (GB) | 2002-05-22 | — | — | CN | disclosed |
| EP-0296221-B1 | PROCESS FOR PREPARING 4,6-DINITRORESORCINOL | THE DOW CHEMICAL COMPANY (US) | 1992-05-13 | — | — | EP | disclosed |
| EP-0296221-A4 | PROCESS FOR PREPARING 4,6-DINITRORESORCINOL. | STANFORD RES INST INT (US) | 1989-04-24 | — | — | EP | disclosed |
| EP-0296221-A1 | PROCESS FOR PREPARING 4,6-DINITRORESORCINOL. | STANFORD RES INST INT (US) | 1988-12-28 | — | — | EP | disclosed |
| WO-1988005038-A1 | PROCESS FOR PREPARING 4,6-DINITRORESORCINOL | SRI INTERNATIONAL (US) | 1988-07-14 | — | — | WO | disclosed |
| US-4745232-A | NITRATION, PRECIPITATION | SRI INTERNATIONAL (US) | 1988-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180200199-A1 | PATCH FOR TREATING DERMATOPHYTOSIS | DPM1, KRT18, LCP1 | GPR35 3028/4885CYP3A4 4647/4885KMT2A 183/4885 |
| US-10123978-B2 | Patch for treating dermatophytosis | DPM1, KRT18, LCP1 | GPR35 3028/4885CYP3A4 4647/4885KMT2A 183/4885 |
| US-20150209301-A1 | PATCH FOR ANTI-DERMATOPHYTOSIS | CUTA, NACA, POLR1C | GPR35 2468/4885CYP3A4 4282/4885KMT2A 727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.